全文获取类型
收费全文 | 2746篇 |
免费 | 347篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 143篇 |
妇产科学 | 28篇 |
基础医学 | 192篇 |
口腔科学 | 43篇 |
临床医学 | 346篇 |
内科学 | 769篇 |
皮肤病学 | 78篇 |
神经病学 | 281篇 |
特种医学 | 321篇 |
外科学 | 371篇 |
综合类 | 48篇 |
预防医学 | 138篇 |
眼科学 | 50篇 |
药学 | 179篇 |
中国医学 | 4篇 |
肿瘤学 | 110篇 |
出版年
2023年 | 63篇 |
2022年 | 28篇 |
2021年 | 57篇 |
2020年 | 100篇 |
2019年 | 22篇 |
2018年 | 108篇 |
2017年 | 80篇 |
2016年 | 86篇 |
2015年 | 94篇 |
2014年 | 149篇 |
2013年 | 175篇 |
2012年 | 128篇 |
2011年 | 112篇 |
2010年 | 111篇 |
2009年 | 138篇 |
2008年 | 90篇 |
2007年 | 103篇 |
2006年 | 93篇 |
2005年 | 83篇 |
2004年 | 57篇 |
2003年 | 52篇 |
2002年 | 56篇 |
2001年 | 56篇 |
2000年 | 39篇 |
1999年 | 46篇 |
1998年 | 88篇 |
1997年 | 101篇 |
1996年 | 84篇 |
1995年 | 75篇 |
1994年 | 58篇 |
1993年 | 57篇 |
1992年 | 40篇 |
1991年 | 28篇 |
1990年 | 35篇 |
1989年 | 62篇 |
1988年 | 47篇 |
1987年 | 38篇 |
1986年 | 25篇 |
1985年 | 34篇 |
1984年 | 29篇 |
1983年 | 20篇 |
1982年 | 20篇 |
1981年 | 16篇 |
1980年 | 16篇 |
1979年 | 13篇 |
1978年 | 18篇 |
1977年 | 15篇 |
1976年 | 14篇 |
1975年 | 9篇 |
1971年 | 8篇 |
排序方式: 共有3135条查询结果,搜索用时 31 毫秒
1.
2.
Suraj Kumar Kulkarni Nagaraja Moorthy Rangaraj Ramalingam 《Echocardiography (Mount Kisco, N.Y.)》2019,36(3):598-601
Antiphospholipid antibody syndrome (APLS) is a rare disorder characterized by a hypercoagulable state. Manifestations include arterial or venous thrombosis, recurrent fetal wastage, coronary artery disease, valvular heart disease, dilated cardiomyopathy, pulmonary artery hypertension, and intracardiac thrombus. Most commonly mitral valve is affected followed by aortic and then tricuspid valve. In this report, a rare case of spontaneous aortic thrombosis with tricuspid stenosis uncomplicated by other valve lesions is presented with clinical and echocardiographic studies and computed tomographic images. 相似文献
3.
N. S. Hari Narayana Moorthy Sergio F. Sousa Maria J. Ramos Pedro A. Fernandes 《Medicinal chemistry research》2016,25(7):1340-1357
Farnesyltransferase (FTase) is one of the prenyltransferase family enzymes that catalyse the transfer of 15-membered isoprenoid (farnesyl) moiety to the cysteine of CAAX motif-containing proteins including Rho and Ras family of G proteins. Inhibitors of FTase act as drugs for cancer, malaria, progeria and other diseases. In the present investigation, we have developed two structure-based pharmacophore models from protein–ligand complex (3E33 and 3E37) obtained from the protein data bank. Molecular dynamics (MD) simulations were performed on the complexes, and different conformers of the same complex were generated. These conformers were undergone protein–ligand interaction fingerprint (PLIF) analysis, and the fingerprint bits have been used for structure-based pharmacophore model development. The PLIF results showed that Lys164, Tyr166, TrpB106 and TyrB361 are the major interacting residues in both the complexes. The RMSD and RMSF analyses on the MD-simulated systems showed that the absence of FPP in the complex 3E37 has significant effect in the conformational changes of the ligands. During this conformational change, some interactions between the protein and the ligands are lost, but regained after some simulations (after 2 ns). The structure-based pharmacophore models showed that the hydrophobic and acceptor contours are predominantly present in the models. The pharmacophore models were validated using reference compounds, which significantly identified as HITs with smaller RMSD values. The developed structure-based pharmacophore models are significant, and the methodology used in this study is novel from the existing methods (the original X-ray crystallographic coordination of the ligands is used for the model building). In our study, along with the original coordination of the ligand, different conformers of the same complex (protein–ligand) are used. It concluded that the developed methodology is significant for the virtual screening of novel molecules on different targets. 相似文献
4.
5.
6.
7.
8.
9.
10.
筛检对肝癌死亡率影响的研究 总被引:5,自引:0,他引:5
5581名HBsAg阳性的男性随机分入周期性筛检组(A组,3712人)及对照组(B组,1869人)。A组(19155.4人年)共发生肝癌257例,B组(9785.5人年)为117例,两组的肝癌发生率分别为1342/10万与1196/10万;两组肝癌死亡分别为218与109例,肝癌死亡率分别为1138/10万与1114/10万。两组中Ⅰ期肝癌病例分别为29.6%与6.0%,差异有非常显著性意义。1、3、5年相对生存率A组为23.7%、7.0%、4.0%,B组为9.7%、4.0%、4.1%。用Poisson回归模型拟合显示,在调正年龄、初筛AFP及入列年份后,筛检对于肝癌的相对危险度为0.83,95%CI为0.68~1.03,有较弱的“保护”作用,Cox回归模型拟合结果显示当临床分期未引入模型时,筛检对于肝癌有显著的“保护”作用:危险率为0.6617,95%CI为0.5234~0.8365;而模型经调整后,危险率即接近“1”,95%CI为0.74~1.26。 相似文献